{"id":451467,"date":"2021-03-04T17:33:14","date_gmt":"2021-03-04T22:33:14","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=451467"},"modified":"2021-03-04T17:33:14","modified_gmt":"2021-03-04T22:33:14","slug":"plx-pharma-inc-to-discuss-2020-fourth-quarter-financial-results-on-march-12-2021-conference-call-and-provide-business-update","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/plx-pharma-inc-to-discuss-2020-fourth-quarter-financial-results-on-march-12-2021-conference-call-and-provide-business-update\/","title":{"rendered":"PLx Pharma Inc. to Discuss 2020 Fourth Quarter Financial Results on March 12, 2021 Conference Call and Provide Business Update"},"content":{"rendered":"
\n

SPARTA, N.J., March 04, 2021 (GLOBE NEWSWIRE) — PLx Pharma Inc. (NASDAQ: PLXP) (\u201cPLx\u201d or the \u201cCompany\u201d), a late-stage specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard\u2122 drug delivery platform designed to provide more effective and safer products, announced today that the Company will release its 2020 fourth quarter financial results on Friday, March 12, 2021, before the U.S. financial markets open.<\/p>\n

Natasha Giordano, President and Chief Executive Officer, and Rita O\u2019Connor, Chief Financial Officer, will host a conference call to discuss the results and provide a business update as follows:<\/p>\n\n\n\n\n\n\n\n
Date<\/td>\nFriday, March 12, 2021<\/td>\n<\/tr>\n
Time<\/td>\n8:30 a.m. ET<\/td>\n<\/tr>\n
Toll free (U.S.)<\/td>\n(866) 394-2901<\/td>\n<\/tr>\n
International
Conference ID<\/td>\n		(616) 548-5567
7293573<\/td>\n<\/tr>\n
Webcast (live and replay)<\/td>\n\n www.plxpharma.com<\/a> under the \u2018Investor Relations\u2019 section.<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n<\/table>\n

A replay of the conference call will be available for two weeks after the call’s completion by dialing (855) 859-2056 (U.S.) or (404) 537-3406 (International). The conference ID for the replay is 7293573. The archived webcast will be available for 30 days via the aforementioned URL.<\/p>\n

\n About VAZALORE <\/strong>
\n
VAZALORE is an FDA-approved liquid-filled aspirin capsule that provides patients with vascular disease and diabetic patients who are candidates for aspirin therapy based on physician recommendation, with fast, reliable and predictable platelet inhibition as compared to enteric-coated aspirin. It also reduces the risk of stomach erosions and ulcers, as compared to immediate-release aspirin, common in an acute setting.<\/p>\n

\n About PLx Pharma Inc.\u00a0<\/strong>
\n
PLx Pharma Inc. is a late-stage specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard\u2122 drug delivery platform to provide more effective and safer products. The PLxGuard drug delivery platform works by targeting the release of active pharmaceutical ingredients to various portions of the gastrointestinal (GI) tract. PLx believes this platform has the potential to improve the absorption of many drugs currently on the market or in development, and to reduce the risk of stomach erosions and ulcers associated with certain drugs.<\/p>\n

To learn more about\u00a0PLx Pharma Inc. and its pipeline, please\u00a0visit www.plxpharma.com<\/u><\/a>.<\/p>\n

\n Contact <\/strong>
\n
Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com<\/a>
Source: PLx Pharma Inc.<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

SPARTA, N.J., March 04, 2021 (GLOBE NEWSWIRE) — PLx Pharma Inc. (NASDAQ: PLXP) (\u201cPLx\u201d or the \u201cCompany\u201d), a late-stage specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard\u2122 drug delivery platform designed to provide more effective and safer products, announced today that the Company will release its 2020 fourth quarter financial results on Friday, March 12, 2021, before the U.S. financial markets open. Natasha Giordano, President and Chief Executive Officer, and Rita O\u2019Connor, Chief Financial Officer, will host a conference call to discuss the results and provide a business update as follows: Date Friday, March 12, 2021 Time 8:30 a.m. ET Toll free (U.S.) (866) 394-2901 InternationalConference ID (616) 548-55677293573 Webcast (live and replay) www.plxpharma.com under the \u2018Investor Relations\u2019 … <\/p>\n

Continue reading “PLx Pharma Inc. to Discuss 2020 Fourth Quarter Financial Results on March 12, 2021 Conference Call and Provide Business Update”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-451467","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nPLx Pharma Inc. to Discuss 2020 Fourth Quarter Financial Results on March 12, 2021 Conference Call and Provide Business Update - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/plx-pharma-inc-to-discuss-2020-fourth-quarter-financial-results-on-march-12-2021-conference-call-and-provide-business-update\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PLx Pharma Inc. to Discuss 2020 Fourth Quarter Financial Results on March 12, 2021 Conference Call and Provide Business Update - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SPARTA, N.J., March 04, 2021 (GLOBE NEWSWIRE) — PLx Pharma Inc. (NASDAQ: PLXP) (\u201cPLx\u201d or the \u201cCompany\u201d), a late-stage specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard\u2122 drug delivery platform designed to provide more effective and safer products, announced today that the Company will release its 2020 fourth quarter financial results on Friday, March 12, 2021, before the U.S. financial markets open. Natasha Giordano, President and Chief Executive Officer, and Rita O\u2019Connor, Chief Financial Officer, will host a conference call to discuss the results and provide a business update as follows: Date Friday, March 12, 2021 Time 8:30 a.m. ET Toll free (U.S.) (866) 394-2901 InternationalConference ID (616) 548-55677293573 Webcast (live and replay) www.plxpharma.com under the \u2018Investor Relations\u2019 … Continue reading "PLx Pharma Inc. to Discuss 2020 Fourth Quarter Financial Results on March 12, 2021 Conference Call and Provide Business Update"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/plx-pharma-inc-to-discuss-2020-fourth-quarter-financial-results-on-march-12-2021-conference-call-and-provide-business-update\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-04T22:33:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDk0MCM0MDQ5ODA0IzIwMjAyMjU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/plx-pharma-inc-to-discuss-2020-fourth-quarter-financial-results-on-march-12-2021-conference-call-and-provide-business-update\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/plx-pharma-inc-to-discuss-2020-fourth-quarter-financial-results-on-march-12-2021-conference-call-and-provide-business-update\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"PLx Pharma Inc. to Discuss 2020 Fourth Quarter Financial Results on March 12, 2021 Conference Call and Provide Business Update\",\"datePublished\":\"2021-03-04T22:33:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/plx-pharma-inc-to-discuss-2020-fourth-quarter-financial-results-on-march-12-2021-conference-call-and-provide-business-update\\\/\"},\"wordCount\":360,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/plx-pharma-inc-to-discuss-2020-fourth-quarter-financial-results-on-march-12-2021-conference-call-and-provide-business-update\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDk0MCM0MDQ5ODA0IzIwMjAyMjU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/plx-pharma-inc-to-discuss-2020-fourth-quarter-financial-results-on-march-12-2021-conference-call-and-provide-business-update\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/plx-pharma-inc-to-discuss-2020-fourth-quarter-financial-results-on-march-12-2021-conference-call-and-provide-business-update\\\/\",\"name\":\"PLx Pharma Inc. to Discuss 2020 Fourth Quarter Financial Results on March 12, 2021 Conference Call and Provide Business Update - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/plx-pharma-inc-to-discuss-2020-fourth-quarter-financial-results-on-march-12-2021-conference-call-and-provide-business-update\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/plx-pharma-inc-to-discuss-2020-fourth-quarter-financial-results-on-march-12-2021-conference-call-and-provide-business-update\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDk0MCM0MDQ5ODA0IzIwMjAyMjU=\",\"datePublished\":\"2021-03-04T22:33:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/plx-pharma-inc-to-discuss-2020-fourth-quarter-financial-results-on-march-12-2021-conference-call-and-provide-business-update\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/plx-pharma-inc-to-discuss-2020-fourth-quarter-financial-results-on-march-12-2021-conference-call-and-provide-business-update\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/plx-pharma-inc-to-discuss-2020-fourth-quarter-financial-results-on-march-12-2021-conference-call-and-provide-business-update\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDk0MCM0MDQ5ODA0IzIwMjAyMjU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NDk0MCM0MDQ5ODA0IzIwMjAyMjU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/plx-pharma-inc-to-discuss-2020-fourth-quarter-financial-results-on-march-12-2021-conference-call-and-provide-business-update\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PLx Pharma Inc. to Discuss 2020 Fourth Quarter Financial Results on March 12, 2021 Conference Call and Provide Business Update\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PLx Pharma Inc. to Discuss 2020 Fourth Quarter Financial Results on March 12, 2021 Conference Call and Provide Business Update - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/plx-pharma-inc-to-discuss-2020-fourth-quarter-financial-results-on-march-12-2021-conference-call-and-provide-business-update\/","og_locale":"en_US","og_type":"article","og_title":"PLx Pharma Inc. to Discuss 2020 Fourth Quarter Financial Results on March 12, 2021 Conference Call and Provide Business Update - Market Newsdesk","og_description":"SPARTA, N.J., March 04, 2021 (GLOBE NEWSWIRE) — PLx Pharma Inc. (NASDAQ: PLXP) (\u201cPLx\u201d or the \u201cCompany\u201d), a late-stage specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard\u2122 drug delivery platform designed to provide more effective and safer products, announced today that the Company will release its 2020 fourth quarter financial results on Friday, March 12, 2021, before the U.S. financial markets open. Natasha Giordano, President and Chief Executive Officer, and Rita O\u2019Connor, Chief Financial Officer, will host a conference call to discuss the results and provide a business update as follows: Date Friday, March 12, 2021 Time 8:30 a.m. ET Toll free (U.S.) (866) 394-2901 InternationalConference ID (616) 548-55677293573 Webcast (live and replay) www.plxpharma.com under the \u2018Investor Relations\u2019 … Continue reading \"PLx Pharma Inc. to Discuss 2020 Fourth Quarter Financial Results on March 12, 2021 Conference Call and Provide Business Update\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/plx-pharma-inc-to-discuss-2020-fourth-quarter-financial-results-on-march-12-2021-conference-call-and-provide-business-update\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-04T22:33:14+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDk0MCM0MDQ5ODA0IzIwMjAyMjU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/plx-pharma-inc-to-discuss-2020-fourth-quarter-financial-results-on-march-12-2021-conference-call-and-provide-business-update\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/plx-pharma-inc-to-discuss-2020-fourth-quarter-financial-results-on-march-12-2021-conference-call-and-provide-business-update\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"PLx Pharma Inc. to Discuss 2020 Fourth Quarter Financial Results on March 12, 2021 Conference Call and Provide Business Update","datePublished":"2021-03-04T22:33:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/plx-pharma-inc-to-discuss-2020-fourth-quarter-financial-results-on-march-12-2021-conference-call-and-provide-business-update\/"},"wordCount":360,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/plx-pharma-inc-to-discuss-2020-fourth-quarter-financial-results-on-march-12-2021-conference-call-and-provide-business-update\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDk0MCM0MDQ5ODA0IzIwMjAyMjU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/plx-pharma-inc-to-discuss-2020-fourth-quarter-financial-results-on-march-12-2021-conference-call-and-provide-business-update\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/plx-pharma-inc-to-discuss-2020-fourth-quarter-financial-results-on-march-12-2021-conference-call-and-provide-business-update\/","name":"PLx Pharma Inc. to Discuss 2020 Fourth Quarter Financial Results on March 12, 2021 Conference Call and Provide Business Update - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/plx-pharma-inc-to-discuss-2020-fourth-quarter-financial-results-on-march-12-2021-conference-call-and-provide-business-update\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/plx-pharma-inc-to-discuss-2020-fourth-quarter-financial-results-on-march-12-2021-conference-call-and-provide-business-update\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDk0MCM0MDQ5ODA0IzIwMjAyMjU=","datePublished":"2021-03-04T22:33:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/plx-pharma-inc-to-discuss-2020-fourth-quarter-financial-results-on-march-12-2021-conference-call-and-provide-business-update\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/plx-pharma-inc-to-discuss-2020-fourth-quarter-financial-results-on-march-12-2021-conference-call-and-provide-business-update\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/plx-pharma-inc-to-discuss-2020-fourth-quarter-financial-results-on-march-12-2021-conference-call-and-provide-business-update\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDk0MCM0MDQ5ODA0IzIwMjAyMjU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NDk0MCM0MDQ5ODA0IzIwMjAyMjU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/plx-pharma-inc-to-discuss-2020-fourth-quarter-financial-results-on-march-12-2021-conference-call-and-provide-business-update\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"PLx Pharma Inc. to Discuss 2020 Fourth Quarter Financial Results on March 12, 2021 Conference Call and Provide Business Update"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/451467","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=451467"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/451467\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=451467"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=451467"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=451467"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}